| Literature DB >> 17110450 |
Brian Becknell1, Tiffany L Hughes, Aharon G Freud, Bradley W Blaser, Jianhua Yu, Rossana Trotta, Hsiaoyin C Mao, Marie L Caligiuri de Jesús, Mohamad Alghothani, Don M Benson, Amy Lehman, David Jarjoura, Danilo Perrotti, Michael D Bates, Michael A Caligiuri.
Abstract
Natural killer (NK) cells contribute to host immunity, including tumor surveillance, through the production of interferon gamma (IFN-gamma). Although there is some knowledge about molecular mechanisms that induce IFN-gamma in NK cells, considerably less is known about the mechanisms that reduce its expression. Here, we investigate the role of the Hlx transcription factor in IFN-gamma production by NK cells. Hlx expression is induced in monokine-activated NK cells, but with delayed kinetics compared to IFN-gamma. Ectopic Hlx expression decreases IFN-gamma synthesis in primary human NK cells and IFN-gamma promoter activity in an NK-like cell line. Hlx protein levels inversely correlate with those of STAT4, a requisite factor for optimal IFN-gamma transcription. Mechanistically, we provide evidence indicating that Hlx overexpression accelerates dephosphorylation and proteasome-dependent degradation of the active Y693-phosphorylated form of STAT4. Thus, Hlx expression in activated NK cells temporally controls and limits the monokine-induced production of IFN-gamma, in part through the targeted depletion of STAT4.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17110450 PMCID: PMC1852195 DOI: 10.1182/blood-2006-10-050096
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113